A second, distinct mechanism involves dysregulated production of 1,25-dihydroxyvitamin D. Tumor cells and tumor-associated macrophages may aberrantly express 25-hydroxyvitamin D3-1α-hydroxylase (CYP27B1), which is not suppressed by PTH or serum calcium. The gene discussed is PTH; the disease is neoplasm.